ESC Premium Access

Non-vitamin K antagonist oral anticoagulant discontinuation in non-valvular atrial fibrillation patients (ASPECT-NOAC)

Presentation

About the speaker

Doctor Emre Asilturk

Antalya Education and Research Hospital, Antalya (Turkey)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Hyogo, JP)

Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Doctor E. Asilturk, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Atrial fibrillation in heart failure: pharmacological or ablation therapy? – discussion.

27 August 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: how to implement the guidelines and take-home message.

27 August 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: case presentation.

27 August 2021

This platform is supported by

logo Novo Nordisk